Category : Probiotics

Short-chain fatty acids (SCFAs) (such as acetate, propionate, butyrate) are byproducts of bacterial fermentation in the gut and are frequently reduced in people with diabetes, obesity, autoimmune disorders, and cancer. A growing body of research points to the role of SCFAs in governing the mechanism by which the gut microbiome affects host physiology - an exciting prospect considering the current…

Megan Mouw
Megan Mouw holds a Bachelor of Science in microbiology from McGill University (Canada). Driven by her experiences at UCSF medical center in San Francisco, Megan is passionate about the role that the gut microbiota plays in maintaining health and wellness. She is currently perusing graduate studies in Microbiology and Environmental Toxicology at the University of California Santa Cruz and hopes to share her love of science through writing.

Short-chain fatty acids (SCFAs) (such as acetate, propionate, butyrate) are byproducts of bacterial fermentation in the gut and are frequently reduced in people with diabetes, obesity, autoimmune disorders, and cancer. A growing body of research points to the role of SCFAs in governing the mechanism by which the gut microbiome affects host physiology - an exciting prospect considering the current…

Megan Mouw
Megan Mouw holds a Bachelor of Science in microbiology from McGill University (Canada). Driven by her experiences at UCSF medical center in San Francisco, Megan is passionate about the role that the gut microbiota plays in maintaining health and wellness. She is currently perusing graduate studies in Microbiology and Environmental Toxicology at the University of California Santa Cruz and hopes to share her love of science through writing.

Surf the web and you’ll find many claims about probiotics, but many times what’s said isn’t based on fact. Sometimes this is because the author just doesn’t know the science. Sometimes it seems to be intentional, to promote some aspect of one product as better than other products. The International Scientific Association for Probiotics and Prebiotics (ISAPP) created an infographic…

Mary Ellen Sanders
Mary Ellen Sanders is a consultant in the area of probiotic microbiology, with special expertise on paths to scientific substantiation of probiotic product label claims. Dr. Sanders served as the founding president of the International Scientific Association for Probiotics and Prebiotics (ISAPP) and is currently the organization’s Director of Scientific Affairs/ Executive Officer. This international, non-profit association of academic and industrial scientists is dedicated to advancing the science of probiotics and prebiotics (www.isapp.net). Through numerous written, oral and video pieces, including a website, www.usprobiotics.org, she strives to provide objective, evidence-based information on probiotics for consumers and professionals. Key activities include: Panels to determine GRAS status of probiotic strains ; member of the American Gastroenterological Association Scientific Advisory Board for AGA Center for Gut Microbiome Research and Education ; World Gastroenterology Organisation Committee preparing practice guidelines for the use of probiotics and prebiotics for GI indications (2008, 2011, 2014) ; working group convened by the FAO/WHO that developed guidelines for probiotics (2002).

Surf the web and you’ll find many claims about probiotics, but many times what’s said isn’t based on fact. Sometimes this is because the author just doesn’t know the science. Sometimes it seems to be intentional, to promote some aspect of one product as better than other products. The International Scientific Association for Probiotics and Prebiotics (ISAPP) created an infographic…

Mary Ellen Sanders
Mary Ellen Sanders is a consultant in the area of probiotic microbiology, with special expertise on paths to scientific substantiation of probiotic product label claims. Dr. Sanders served as the founding president of the International Scientific Association for Probiotics and Prebiotics (ISAPP) and is currently the organization’s Director of Scientific Affairs/ Executive Officer. This international, non-profit association of academic and industrial scientists is dedicated to advancing the science of probiotics and prebiotics (www.isapp.net). Through numerous written, oral and video pieces, including a website, www.usprobiotics.org, she strives to provide objective, evidence-based information on probiotics for consumers and professionals. Key activities include: Panels to determine GRAS status of probiotic strains ; member of the American Gastroenterological Association Scientific Advisory Board for AGA Center for Gut Microbiome Research and Education ; World Gastroenterology Organisation Committee preparing practice guidelines for the use of probiotics and prebiotics for GI indications (2008, 2011, 2014) ; working group convened by the FAO/WHO that developed guidelines for probiotics (2002).

The prevalence of obesity and related metabolic conditions is increasing worldwide and has become a major public health issue. Recent research has highlighted the gut microbiome's contribution to the development of non-communicable diseases, although little is known about underlying mechanisms and causal relationships. A new study led by Prof. Harry Sokol, a gastroenterologist and researcher from the French National Institute…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

The prevalence of obesity and related metabolic conditions is increasing worldwide and has become a major public health issue. Recent research has highlighted the gut microbiome's contribution to the development of non-communicable diseases, although little is known about underlying mechanisms and causal relationships. A new study led by Prof. Harry Sokol, a gastroenterologist and researcher from the French National Institute…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

New developments in genetics and metagenomics over the past 15 years have led scientists to produce an in-depth characterization of the composition and function of the gut microbiome as a novel organ in the close intersection between health and disease. As a result, the number of publications discussing the gut microbiota over the past five years represents more than 80%…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

New developments in genetics and metagenomics over the past 15 years have led scientists to produce an in-depth characterization of the composition and function of the gut microbiome as a novel organ in the close intersection between health and disease. As a result, the number of publications discussing the gut microbiota over the past five years represents more than 80%…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

How the gut microbiota can relate to preventing and treating obesity and what are the potential gut microbiota targets in gluten-related disorders were the key subjects discussed in the workshop on nutrition organized by GMFH during the Gut Microbiota for Health World Summit 2018, held in Rome on March 10 and 11. The workshop, called ‘Gut microbiota targets in nutrition’,…

GMFH Editing Team
GMFH Editing Team

How the gut microbiota can relate to preventing and treating obesity and what are the potential gut microbiota targets in gluten-related disorders were the key subjects discussed in the workshop on nutrition organized by GMFH during the Gut Microbiota for Health World Summit 2018, held in Rome on March 10 and 11. The workshop, called ‘Gut microbiota targets in nutrition’,…

GMFH Editing Team
GMFH Editing Team

A growing number of scientific studies show the diet can affect health through the gut microbiota. However, foods and dietary patterns actually have differing effects on the gut microbiota between individuals. In modulating the gut microbiota of infants, prebiotics and probiotics could turn out to be useful. Treatments with specific probiotics could help regulate an unbalanced microbiota and thus improve,…

GMFH Editing Team
GMFH Editing Team

A growing number of scientific studies show the diet can affect health through the gut microbiota. However, foods and dietary patterns actually have differing effects on the gut microbiota between individuals. In modulating the gut microbiota of infants, prebiotics and probiotics could turn out to be useful. Treatments with specific probiotics could help regulate an unbalanced microbiota and thus improve,…

GMFH Editing Team
GMFH Editing Team

Obesity currently affects up to 650 million people worldwide and this figure has doubled since 1980. Of the environmental factors that may contribute to the development of obesity, gut microbiota is in the spotlight, given that it may be involved in the low-grade inflammatory process and subsequent disrupted glucose metabolism and fat absorption that are features of obesity. Epidemiological research…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Obesity currently affects up to 650 million people worldwide and this figure has doubled since 1980. Of the environmental factors that may contribute to the development of obesity, gut microbiota is in the spotlight, given that it may be involved in the low-grade inflammatory process and subsequent disrupted glucose metabolism and fat absorption that are features of obesity. Epidemiological research…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

The identification of an isolate at the strain level has been considered an essential requirement for any microbe that is intended to be commercialized as a probiotic. Strain-level identity is essential for both safety and efficacy evaluations. It enables traceability in laboratory tests, clinical trials and throughout the production and commercialization process. Although the health benefits of probiotics have been…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

The identification of an isolate at the strain level has been considered an essential requirement for any microbe that is intended to be commercialized as a probiotic. Strain-level identity is essential for both safety and efficacy evaluations. It enables traceability in laboratory tests, clinical trials and throughout the production and commercialization process. Although the health benefits of probiotics have been…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

The Gut Microbiota for Health publishing team is delighted to share the second summary document on the latest scientific work related to gut microbiota and probiotics! With gastrointestinal (GI) symptoms high in prevalence throughout the world, and with limited available therapeutic options for addressing functional GI disorders, is there a role for probiotics? This document covers human research that elucidates…

GMFH Editing Team
GMFH Editing Team

The Gut Microbiota for Health publishing team is delighted to share the second summary document on the latest scientific work related to gut microbiota and probiotics! With gastrointestinal (GI) symptoms high in prevalence throughout the world, and with limited available therapeutic options for addressing functional GI disorders, is there a role for probiotics? This document covers human research that elucidates…

GMFH Editing Team
GMFH Editing Team
Canadian Obesity Network

Although plenty of research in both animal models and humans during the last decade has explored the relationship between the gut microbiota and obesity and related metabolic disorders, the clinically relevant contribution of gut microbiota to obesity and related metabolic disorders is still unknown. The relationship between obesity and metabolic diseases has been recently covered in a review article by…

GMFH Editing Team
GMFH Editing Team

Canadian Obesity Network

Although plenty of research in both animal models and humans during the last decade has explored the relationship between the gut microbiota and obesity and related metabolic disorders, the clinically relevant contribution of gut microbiota to obesity and related metabolic disorders is still unknown. The relationship between obesity and metabolic diseases has been recently covered in a review article by…

GMFH Editing Team
GMFH Editing Team